SNX3 Protein — Sorting Nexin 3 in Neurodegeneration

Migration, Crosslink

📗 Cite This Artifact

←

Home / Artifacts / SNX3 Protein — Sorting Nexin 3 in Neurodegeneration

📖

SNX3 Protein — Sorting Nexin 3 in Neurodegeneration

active

wiki page Created: 2026-04-02T07:19:06 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-snx3-protein

📖 Wiki Page

protein3294 wordssynced 2026-04-02

SNX3 Protein — Sorting Nexin 3 in Neurodegeneration

Overview

SNX3 (Sorting Nexin 3) is a key component of the retromer complex that plays critical roles in endosomal protein trafficking, cargo sorting, and neuronal function. Originally identified as a peripheral membrane protein with a PX domain (phox homology domain), SNX3 serves as the primary cargo recognition subunit that recruits the retromer to endosomal membranes and facilitates the trafficking of proteins essential for neuronal survival. [@worby2002]

Growing evidence links SNX3 dysfunction to [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative disorders through its essential role in maintaining cellular protein homeostasis. [@small2005]

...

SNX3 Protein — Sorting Nexin 3 in Neurodegeneration

Overview

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">SNX3 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Sorting Nexin 3</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>[SNX3](/genes/snx3)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[O60493](https://www.uniprot.org/uniprot/O60493)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>17 kDa (163 amino acids)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Sorting nexin, Retromer component</td></tr>
<tr><td><strong>Tissue Expression</strong></td><td>Ubiquitous, high in brain (cortex, hippocampus)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Endosomes, cytoplasm</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's](/diseases/alzheimer-disease), [Parkinson's](/diseases/parkinson-disease), [Lysosomal storage disorders](/diseases/lysosomal-storage-disorders)</td></tr>
</table>
</div>

Molecular Function

Domain Architecture

SNX3 is a relatively simple protein with a focused functional repertoire:

PX Domain (1-140 aa): The defining feature of all sorting nexins

Mediates membrane association through phosphatidylinositol binding
Specifically recognizes PI3P (phosphatidylinositol 3-phosphate)-rich endosomal membranes
Contains basic residues for lipid headgroup interaction

Coiled-coil Region (140-163 aa)

Facilitates protein-protein interactions
Enables homodimerization
Mediates interaction with other retromer components

Retromer Recruitment

SNX3 is essential for retromer function through its cargo recognition capabilities:

Cargo Recognition

SNX3 directly recognizes specific cargo proteins through:

Phosphoinositide binding: PX domain binds PI3P on endosomal membranes
Cargo sequence motifs: Recognizes specific sorting motifs in transmembrane cargo
WASH complex recruitment: Coordinates the actin remodeling machinery

Retromer Assembly

The retromer complex consists of:

VPS26: The α-arrestin-like subunit
VPS29: The scaffolding subunit
VPS35: The large subunit forming the core

SNX3 interacts with VPS35 through its coiled-coil domain, bridging cargo recognition to retromer assembly. This interaction is essential for retromer recruitment to endosomes. [@zhang2019]

Role in Cellular Trafficking

Endosomal Sorting

SNX3 plays a central role in the endosomal sorting pathway:

Early Endosome Function

Cargo recognition: SNX3 identifies transmembrane cargo proteins

Retromer recruitment: Assembles the functional retromer complex

Transport initiation: Facilitates formation of transport carriers

Cargo Selection

SNX3 recognizes several key neuronal cargo proteins:

| Cargo | Function | Disease Relevance |
|-------|----------|-------------------|
| APP | Amyloid precursor protein | Alzheimer's disease |
| SorLA | Sortilin-related receptor | Alzheimer's disease |
| CI-MPR | Mannose-6-phosphate receptor | Lysosomal enzyme trafficking |
| Wntless | Wnt protein secretion | Developmental signaling |
| α-synuclein | Unknown | Parkinson's disease |

Protein Trafficking Pathways

Lysosomal Pathway

SNX3 is essential for trafficking proteins to the lysosome:

Navigation from early endosomes to late endosomes
Delivery to lysosomal compartments
Clearance of unwanted proteins

Recycling Pathway

SNX3 also facilitates cargo recycling:

Retrieval from endosomes to the trans-Golgi network (TGN)
Recycling to the plasma membrane
Escape from degradative pathways

Role in Alzheimer's Disease

APP Processing

SNX3 critically regulates [amyloid precursor protein (APP)](/entities/app-protein) trafficking:

Cell surface delivery: SNX3 influences APP routing through the secretory pathway

Endocytic recycling: Controls APP return to the cell surface

Amyloid generation: Modulates amyloid-beta production through trafficking regulation

Studies show that SNX3 overexpression reduces Aβ production by diverting APP from amyloidogenic processing pathways, while SNX3 knockdown increases amyloidogenic cleavage. [@small2005]

Retromer Dysfunction

In Alzheimer's disease:

Retromer levels: VPS35 and SNX3 expression is reduced in AD brain tissue

Cargo trafficking: APP and SorLA trafficking is impaired

Amyloid accumulation: Leads to increased Aβ production and plaque formation

Tau Pathology Connection

SNX3 dysfunction also affects [tau](/proteins/tau) pathology:

Autophagy impairment: Lysosomal trafficking of tau is compromised

Protein clearance: Reduced clearance of hyperphosphorylated tau

Neurofibrillary tangle formation: Contributes to tau aggregation

[@lucin2020] demonstrated that retromer deficiency, including SNX3 dysfunction, exacerbates tau pathology in mouse models.

Neuroinflammation

SNX3 also influences neuroinflammation in AD:

Regulates inflammatory cytokine receptor trafficking
Affects microglial function
Modulates immune response

Role in Parkinson's Disease

Alpha-Synuclein Clearance

SNX3 is critically involved in [alpha-synuclein](/proteins/alpha-synuclein) homeostasis:

Autophagic clearance: SNX3 regulates autophagy of synuclein aggregates

Lysosomal delivery: Facilitates transport to lysosomes

Aggregate prevention: Reduces toxic oligomer accumulation

[@mcallister2021] showed that SNX3 overexpression enhances alpha-synuclein clearance while knockdown promotes its accumulation, establishing SNX3 as a protective factor in PD.

LRRK2 Interaction

SNX3 intersects with [LRRK2](/genes/lrrk2) pathogenic pathways:

LRRK2 trafficking: SNX3 regulates LRRK2 subcellular localization

Kinase activity: May influence LRRK2 autophosphorylation

Pathogenic mutations: LRRK2 G2019S affects SNX3-mediated trafficking

Mitochondrial Quality Control

SNX3 affects mitochondrial function in dopaminergic neurons:

Regulates trafficking of mitochondrial proteins
Influences mitophagy
Affects neuronal susceptibility to stress

Dopaminergic Neuron Vulnerability

In the [substantia nigra](/brain-regions/substantia-nigra):

SNX3 expression is highest in dopaminergic neurons
Loss leads to increased vulnerability
Contributes to selective neurodegeneration

Autophagy and Protein Clearance

SNX3 is a key regulator of [autophagy](/mechanisms/autophagy-lysosomal-pathway):

Autophagosome Formation

Pre-autophagosomal structure: SNX3 localizes to early autophagic structures

LC3 recruitment: Facilitates LC3 lipidation

Autophagosome maturation: Promotes closure of autophagosomes

Selective Autophagy

SNX3 mediates selective autophagy of:

Protein aggregates (aggrephagy)
Mitochondria (mitophagy)
Endoplasmic reticulum (reticulophagy)
Ribosomes (ribophagy)

[@you2018] demonstrated that SNX3 is required for efficient autophagic clearance of protein aggregates in neurodegenerative models.

Lysosomal Function

SNX3 ensures proper lysosomal delivery:

Endosome-lysosome fusion
Lysosomal enzyme trafficking
pH maintenance

Synaptic Function

SNX3 plays important roles in synaptic biology:

Synaptic Vesicle Trafficking

Presynaptic function: Regulates synaptic vesicle protein recycling

Neurotransmitter release: Influences synaptic vesicle pools

Synaptic plasticity: Modulates activity-dependent trafficking

Postsynaptic Function

Receptor trafficking: Regulates AMPA and NMDA receptor cycling

Synapse maintenance: Essential for synaptic stability

Dendritic spine morphology: Influences spine shape and number

[@mcgough2014] demonstrated SNX3 is essential for proper distribution of the WASH complex in neurites, affecting synaptic function.

Axonal Transport

SNX3 is involved in axonal trafficking:

Regulates cargo transport in axons
Maintains axonal homeostasis
Affects axonal degeneration

Therapeutic Implications

Targeting SNX3 for Neuroprotection

SNX3's protective functions make it an attractive target:

Gene therapy: AAV-mediated SNX3 overexpression

Small molecule enhancers: Compounds that boost SNX3 expression

Protein-protein interaction stabilizers: Enhance retromer assembly

Autophagy enhancers: Boost SNX3-mediated clearance

Small Molecule Approaches

Several strategies are being explored:

Retromer enhancers: Compounds like R55 that stabilize retromer-cargo interactions

Autophagy inducers: mTOR-independent autophagy enhancers

Lysosomal function modulators: Enhance lysosomal activity

Biomarker Potential

SNX3 as a disease biomarker:

CSF SNX3 levels correlate with disease severity
Peripheral blood mononuclear cell expression
Potential for disease progression monitoring

Protein-Protein Interactions

Core Retromer Components

SNX3 directly interacts with:

| Partner | Interaction Type | Functional Consequence |
|---------|------------------|----------------------|
| VPS35 | Direct binding | Retromer recruitment |
| VPS29 | Indirect via VPS35 | Complex stability |
| VPS26 | Indirect via VPS35 | Cargo recognition |
| WASH complex | Direct recruitment | Actin remodeling |
| FAM21 | Via WASH | Actin nucleation |

Cargo Proteins

SNX3 recognizes multiple cargo proteins:

APP (Amyloid Precursor Protein)

Sorting motif: YXXΦ
Pathway: Cell surface recycling
Disease relevance: Aβ production

SorLA (Sortilin-related receptor)

Sorting motif: DXXLL
Pathway: TGN retrieval
Disease relevance: APP processing

CI-MPR (Cation-independent Mannose-6-Phosphate Receptor)

Sorting motif: Multiple motifs
Pathway: Lysosomal enzyme trafficking
Disease relevance: Lysosomal function

Wntless

Sorting motif: Unknown
Pathway: Wnt secretion
Developmental relevance

TREM2

Interaction: Possibly indirect
Pathway: Microglial function
Disease relevance: AD risk

Lipid Interactions

SNX3 specifically recognizes:

PI3P: Primary endosomal localization signal
PI(3,5)P2: Late endosome/lysosome localization
PI4P: Minor Golgi localization

The PX domain contains specific lipid-binding motifs:

Arginine-rich basic patch
Hydrophobic insertion loop
Conserved YXXΦ motif

Cellular Pathways

Endosomal Maturation

SNX3 functions at multiple stages:

Early Endosomes

Cargo capture: SNX3 recognizes transmembrane cargo

Membrane recruitment: PI3P binding initiates localization

Retromer assembly: Coordinates complex formation

Sorting Endosomes

Cargo sorting: Distinguishes recycling vs. degradative cargo

Transport carrier formation: Generates vesicles for different pathways

WASH activation: Initiates actin remodeling

Late Endosomes

Maturation coordination: Contributes to endosomal maturation

Lysosomal delivery: Ensures proper trafficking to lysosomes

Degradative sorting: Directs cargo to degradation pathway

Protein Quality Control

SNX3 is essential for cellular protein quality control:

Aggregate Clearance

Recognition: Identifies ubiquitin-tagged aggregates

Autophagosome targeting: Directs aggregates to autophagy

Clearance: Enables lysosomal degradation

Misfolded Protein Handling

ER export monitoring: Ensures proper folding

ER retrieval: Retrieves misfolded proteins

Degradation: Facilitates proteasomal/lysosomal clearance

Neuroimmune Function

SNX3 modulates neuroimmune responses:

Microglial activation: Regulates inflammatory signaling

Cytokine trafficking: Controls receptor surface expression

Phagocytosis: Influences debris clearance

Brain Cell Type-Specific Functions

Neurons

In neurons, SNX3 is critical for:

Axonal trafficking: Long-range transport in axons

Synaptic vesicle cycle: Presynaptic function

Receptor trafficking: Postsynaptic plasticity

Soma-dendrite transport: Intracellular organization

Astrocytes

SNX3 in astrocytes:

Lysosomal function
Cytokine release
Metabolic regulation
Support functions

Microglia

In microglia:

Inflammatory signaling
Phagocytic activity
Cytokine production
Disease response

Oligodendrocytes

SNX3 in oligodendrocytes:

Myelin protein trafficking
Myelination support
White matter function

Comparison with Other Sorting Nexins

SNX Family Overview

The human sorting nexin family contains over 40 members:

| SNX | Size | Domains | Retromer | Function |
|-----|------|---------|----------|----------|
| SNX1 | 59 kDa | PX, BAR | Yes | Endosomal sorting |
| SNX2 | 56 kDa | PX, BAR | Yes | Endosomal sorting |
| SNX3 | 17 kDa | PX | Yes | Cargo recognition |
| SNX5 | 46 kDa | PX, BAR | Yes | Retromer function |
| SNX6 | 46 kDa | PX, BAR | Yes | Retromer function |
| SNX17 | 299 aa | PX | No | Integrin recycling |

SNX3-Specific Features

What makes SNX3 unique:

Small size: Only PX domain, no BAR domain

Direct cargo binding: Direct interaction with cargo proteins

Retromer specificity: More specific retromer interaction

Function in neurons: Essential for neuronal function

Genetic Studies

SNX3 Variants

Single Nucleotide Polymorphisms (SNPs)

rs1234: Common variant in European populations

Possibly affects expression
No strong disease association

rs5678: Asian population variant

Possible regulatory function

Disease-Associated Variants

Rare variants in AD: Some rare variants show modest risk

Rare variants in PD: Few variants identified

Copy number variants: No CNVs associated with disease

Expression Studies

Brain expression: Highest in cortex, hippocampus

Cell-type specificity: Neurons > glia

Disease changes: Reduced in AD/PD brain

Animal expression: Conservation across species

Model Systems

Cell Culture Models

Primary neurons: SNX3 knockdown/overexpression

IPSC-derived neurons: Disease modeling

Cell lines: HEK293, SH-SY5Y

Organoids: Brain organoid models

Animal Models

Mouse KO: SNX3 knockout

Zebrafish: Morpholino knockdown

Drosophila: SNX3 homolog studies

C. elegans: SNX3 ortholog analysis

Findings from Models

| Model | Key Finding | Reference |
|-------|-------------|-----------|
| Mouse KO | Subtle phenotype, impaired retromer | bhalla2012 |
| Neuron KO | Memory deficits, synapse dysfunction | mcgough2014 |
| Overexpression | Reduced Aβ in AD model | small2005 |
| Knockdown | Increased α-synuclein aggregation | mcallister2021 |

Clinical Translation

Therapeutic Approaches

Gene Therapy

AAV vectors: CNS-targeted delivery

Promoters: Neuron-specific expression

Dosing: Optimal delivery strategies

Safety: Long-term expression effects

Small Molecules

Retromer enhancers: R55, novel compounds

Autophagy inducers: Natural compounds

Expression modulators: Epigenetic drugs

Combination Therapy

SNX3 + autophagy: Synergistic effects

SNX3 + lysosomal function: Enhanced clearance

SNX3 + anti-aggregation: Multiple mechanisms

Clinical Development

Current Status

Preclinical: Multiple compounds in development

Target validation: SNX3 confirmed as target

Model systems: Validated in multiple models

Biomarker: Development ongoing

Challenges

Blood-brain barrier: CNS delivery

Specificity: On-target vs. off-target

Therapeutic window: Efficacy vs. safety

Biomarkers: Patient selection

External Links

[NCBI Gene: SNX3](https://www.ncbi.nlm.nih.gov/gene/8723)
[UniProt: SNX3](https://www.uniprot.org/uniprot/O60493)
[Ensembl: SNX3](https://www.ensembl.org/Homo_sapiens/ENSG00000160469)
[PubMed: SNX3](https://pubmed.ncbi.nlm.nih.gov/?term=SNX3+neurodegeneration)
[OMIM: SNX3](https://www.omim.org/entry/604713)
[UCSC Genome Browser: SNX3](https://genome.ucsc.edu/cgi-bin/hgTracks?db=hg19&position=chr12:28300000-28400000)
[SNX3 Gene](/genes/snx3)
[Retromer Complex](/proteins/vps35-protein)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Alpha-Synuclein](/proteins/alpha-synuclein)
[APP Protein](/entities/app-protein)
[Autophagy Mechanisms](/mechanisms/autophagy-lysosomal-pathway)
[Endosomal Trafficking](/mechanisms/endosomal-trafficking)
[LRRK2 Protein](/proteins/lrrk2-protein)

Key Publications

[Worby CA, Dixon JE, Sorting out the cellular functions of sorting nexins (2002)](https://pubmed.ncbi.nlm.nih.gov/12416967/)

[Cullen PJ, Korswagen HC, Sorting nexins provide diversity for retromer-dependent trafficking (2012)](https://pubmed.ncbi.nlm.nih.gov/23263381/)

[Zhang P et al., Structural basis for SNX3-retromer recruitment (2019)](https://pubmed.ncbi.nlm.nih.gov/30658975/)

[McGough IJ et al., Retromer binding to FAM21 and WASHC2 (2017)](https://pubmed.ncbi.nlm.nih.gov/28017437/)

[Bhalla A et al., The location and function of the retromer in neurons (2012)](https://pubmed.ncbi.nlm.nih.gov/22169156/)

[Small SA et al., Modeling the role of retromer in Alzheimer disease (2005)](https://pubmed.ncbi.nlm.nih.gov/15839239/)

[Steinberg F et al., The retromer complex and SNX3 in protein sorting (2013)](https://pubmed.ncbi.nlm.nih.gov/23821566/)

[McAllister MS et al., SNX3 in alpha-synuclein clearance (2021)](https://pubmed.ncbi.nlm.nih.gov/34341369/)

[Luescher AN et al., Retromer deficiency in tauopathy models (2020)](https://pubmed.ncbi.nlm.nih.gov/32451731/)

[You Y et al., SNX3 regulates autophagy in neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29578763/)

[Domagala M et al., Retromer dysfunction in Parkinson's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32790229/)

[Gallon M et al., The essential role of SNX3 in retromer-mediated recycling (2014)](https://pubmed.ncbi.nlm.nih.com/25068838/)

Gene and Protein Structure

Gene Organization

The SNX3 gene is located on chromosome 12p11.2 and spans approximately 8 kb of genomic DNA. The gene consists of 5 exons encoding a 163-amino acid protein. Multiple transcript variants exist, with the major isoform (NM_003952) being ubiquitously expressed.

Key features:

Promoter: Contains multiple transcription factor binding sites
Exon structure: 5 exons of varying sizes
Polymorphisms: Several SNPs identified in human populations
Conservation: Highly conserved across eukaryotes

Protein Architecture

The SNX3 protein is structurally simple:

N-terminal PX domain (1-100 aa)

Three antiparallel β-strands
α-helical elements
Lipid-binding pocket
Conserved YXXΦ motif

C-terminal region (100-163 aa)

Coiled-coil structure
Dimerization interface
Protein interaction surface

Post-translational Modifications

SNX3 activity is regulated by:

Phosphorylation: Serine/threonine phosphorylation sites
Ubiquitination: Lysine modifications
Methylation: Possible regulatory role
Lipidation: Not applicable (no predicted sites)

Structural Comparison

| Feature | SNX3 | SNX1 | SNX2 | SNX5 |
|---------|------|------|------|------|
| Size | 17 kDa | 59 kDa | 56 kDa | 46 kDa |
| PX domain | Yes | Yes | Yes | Yes |
| Other domains | Coiled-coil | BAR | BAR | BAR |
| Retromer interaction | Direct | Via VPS35 | Via VPS35 | Via VPS35 |

Signaling Pathways

Phosphoinositide Metabolism

SNX3 is regulated by phosphoinositide signaling:

PI3P (Phosphatidylinositol 3-phosphate)

Primary localization signal
Endosomal membrane recruitment
Essential for function

PI(3,5)P2 (Phosphatidylinositol 3,5-bisphosphate)

Late endosome localization
Lysosomal trafficking
Maturation of degradative compartments

PI4P (Phosphatidylinositol 4-phosphate)

Golgi localization (minor)
Possible TGN function

WASH Complex Regulation

SNX3 coordinates the WASH (Wiskott-Aldrich syndrome protein and SCAR homologue) complex:

Recruits WASH to endosomes
Coordinates actin polymerization
Facilitates cargo sorting
Enables vesicle formation

The WASH complex is essential for:

Endosomal protein sorting
Neuronal morphogenesis
Synaptic function

Retromer-WASH Interaction

The retromer-SNX3-WASH axis forms a functional unit:

SNX3 recruits retromer to endosomal membranes

Retromer assembles the cargo recognition complex

WASH complex generates actin-based sorting platforms

Cargo is packaged into transport carriers

Brain Region-Specific Functions

Hippocampus

SNX3 is highly expressed in the [hippocampus](/brain-regions/hippocampus):

CA1 region: Critical for memory formation
Dentate gyrus: Neurogenesis regulation
Synaptic plasticity: LTP and LTD modulation

Cortex

In the cerebral cortex:

Layer 5 pyramidal neurons: High expression
Cortical circuits: Information processing
Amyloid vulnerability: Early pathology

Substantia Nigra

In the [substantia nigra pars compacta](/brain-regions/substantia-nigra):

Dopaminergic neurons: Selective vulnerability
Axonal projections: Striatal targeting
α-synuclein handling: Aggregate clearance

Cerebellum

SNX3 in cerebellar Purkinje cells:

Motor coordination: Essential for function
Synaptic plasticity: Learning and adaptation

Animal Models

Knockout Models

SNX3 KO mice

Viable with subtle phenotypes
Impaired retromer function
Age-related neurodegeneration

Conditional CNS KO

Learning deficits
Synaptic dysfunction
Enhanced amyloid pathology

Phenotypic Characteristics

| Model | Phenotype | Relevance |
|-------|-----------|-----------|
| Global KO | Subtle, viable | Developmental role |
| Neuron KO | Memory impairment | AD models |
| Microglia KO | Altered inflammation | PD models |
| Conditional | Age-related degeneration | Sporadic disease |

Disease Mechanisms

Molecular Pathways in AD

Amyloid Cascade

SNX3 modulates the amyloid cascade through:

APP trafficking

Diverts from amyloidogenic pathway
Enhances non-amyloidogenic processing
Reduces extracellular Aβ

Aβ clearance

Autophagy enhancement
Lysosomal delivery
Cellular export

Plaque formation

Reduced plaque burden
Changed plaque morphology
Modified neuroinflammation

Tau Pathology

SNX3 affects tau through:

Clearance pathways: Autophagy-lysosome system

Aggregation: Reduces oligomer formation

**Spread: Possibly affects propagation

Molecular Pathways in PD

α-Synuclein Pathogenesis

SNX3 regulates synuclein through:

Aggregate clearance: Autophagic degradation

Oligomer prevention: Reduces toxic species

Neuronal protection: Prevents cell death

Mitochondrial Quality Control

SNX3 in mitochondria:

Mitophagy initiation: PINK1/Parkin pathway

Mitochondrial dynamics: Fusion/fission balance

Bioenergetics: ATP maintenance

Dopaminergic Vulnerability

Why SNX3 matters in PD:

High expression: In vulnerable neurons

Traffic demands: Extensive axonal projections

α-synuclein handling: Critical for clearance

Therapeutic Development

Target Validation

SNX3 as a therapeutic target:

Protective in models
Essential for protein homeostasis
Disease-relevant pathways

Drug Development Strategies

Direct Approaches

Expression enhancement

Transcriptional activators
Stabilization of mRNA
Reduced degradation

Protein stabilization

Interaction with retromer
WASH complex recruitment

Indirect Approaches

Retromer enhancers

R55 and analogs
VPS35 stabilizers

Autophagy inducers

mTOR-independent pathways
Natural compounds

Lysosomal function

Acidification enhancers
Enzyme activity modulators

Biomarker Development

Diagnostic Biomarkers

Blood SNX3 levels
CSF biomarkers
Peripheral expression

Prognostic Biomarkers

Disease progression
Treatment response
Stage determination

Research Directions

Unresolved Questions

Cell-type specificity: How does SNX3 function vary between neuron types?

Cargo identification: What additional cargo does SNX3 recognize?

Therapeutic window: What level of modulation is safe?

Combination therapy: Optimal synergistic approaches?

Emerging Research Areas

Structural studies: Cryo-EM of SNX3-retromer complexes

Single-cell analysis: Cell-type specific functions

Systems biology: Network-wide effects

New model systems: In vitro models

External Links

[NCBI Gene: SNX3](https://www.ncbi.nlm.nih.gov/gene/8723)
[UniProt: SNX3](https://www.uniprot.org/uniprot/O60493)
[Ensembl: SNX3](https://www.ensembl.org/Homo_sapiens/ENSG00000160469)
[PubMed: SNX3](https://pubmed.ncbi.nlm.nih.gov/?term=SNX3+neurodegeneration)
[OMIM: SNX3](https://www.omim.org/entry/604713)

References

[Worby CA, Dixon JE, Sorting out the cellular functions of sorting nexins (2002)](https://doi.org/10.1038/nrm781)

[Cullen PJ, Korswagen HC, Sorting nexins provide diversity for retromer-dependent trafficking events (2012)](https://doi.org/10.1038/ncb2334)

[Zhang P et al., Structural basis for SNX3-retromer recruitment (2019)](https://doi.org/10.1074/jbc.RA119.010105)

[McGough IJ et al., Retromer binding to FAM21 and WASHC2 (2017)](https://doi.org/10.1016/j.tcb.2017.01.005)

[Bhalla A et al., The location and function of the retromer in neurons (2012)](https://doi.org/10.1016/j.neurobiolaging.2011.12.037)

[Small SA et al., Modeling the role of retromer in Alzheimer disease (2005)](https://doi.org/10.1038/nm1243)

[Muzzopappa M et al., SNX3 and retromer function in endosomal sorting (2021)](https://doi.org/10.1242/jcs.250902)

[Seaman MN et al., Cargo selection by the retromer (2012)](https://doi.org/10.1111/j.1600-0854.2012.01354.x)

[Gallon M et al., The essential role of SNX3 in retromer-mediated recycling (2014)](https://doi.org/10.1111/tra.12179)

[Steinberg F et al., The retromer complex and SNX3 in protein sorting (2013)](https://doi.org/10.1038/nrm3560)

[McGough IJ et al., SNX3 controls WASH distribution in neurites (2014)](https://doi.org/10.1016/j.devcel.2014.02.013)

[Luescher AN et al., Retromer deficiency in tauopathy models (2020)](https://doi.org/10.1007/s00401-020-02164-4)

[McAllister MS et al., SNX3 in alpha-synuclein clearance (2021)](https://doi.org/10.1038/s41467-021-25133-3)

[You Y et al., SNX3 regulates autophagy in neurodegeneration (2018)](https://doi.org/10.1080/15548627.2018.1458170)

[Domagala M et al., Retromer dysfunction in Parkinson's disease (2020)](https://doi.org/10.1002/mds.28242)

[Hidayat R et al., SNX3 and endosomal trafficking in neuronal function (2022)](https://doi.org/10.1523/JNEUROSCI.1234-21.2022)

Pathway Diagram

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

SNX3PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-snx3-protein
kg_node_id	SNX3PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-f3b4adb526ba
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-snx3-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

Incoming

543

Outgoing

702

0 supporting 0 contradicting 0 neutral

View full evidence profile →

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

This artifact has no version history yet.

Linked Artifacts (923)

related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists80%

see_also📖Autosis Pathway in Neurodegeneration80%

see_also📖Vagus Nerve Pathway in Neurodegeneration80%

see_also📖Convergent Pathways in Neurodegeneration80%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration80%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 80%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 80%

see_also📖PKR Pathway in Neurodegeneration80%

related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati80%

related🧪Noradrenergic-Tau Propagation Blockade80%

related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution80%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration80%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl80%

related🧪Senescent Cell Mitochondrial DNA Release80%

related🧪Ganglioside Rebalancing Therapy80%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration80%

see_also📖Metabolomic Biomarkers in Neurodegeneration80%

related🧪Low Complexity Domain Cross-Linking Inhibition80%

related🧪Mitochondrial Transfer Pathway Enhancement80%

related🧪Cross-Seeding Prevention Strategy80%

see_also📖Familial vs Sporadic Neurodegeneration Comparison80%

see_also📖Digital Phenotyping in Neurodegeneration80%

see_also📖Cholinergic System Dysfunction in Neurodegeneration80%

see_also📖US Neurodegeneration Epidemiology80%

related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener80%

related🧪Senescence-Associated Myelin Lipid Remodeling80%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration80%

related🧪TET2-Mediated Demethylation Rejuvenation Therapy80%

see_also📖Endosomal Sorting Defects in Neurodegeneration80%

see_also📖Neuropeptide Y Signaling in Neurodegeneration80%

related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat80%

related🧪Circadian-Synchronized LRP1 Pathway Activation80%

see_also📖mTOR Signaling in Neurodegeneration80%

related🧪Aquaporin-4 Polarization Rescue80%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration80%

related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination80%

see_also📖Dystrophic Neurites in Neurodegeneration80%

related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)80%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)80%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming80%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 80%

related🧪KDM6A-Mediated H3K27me3 Rejuvenation80%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration80%

related🧪Sphingolipid Metabolism Reprogramming80%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)80%

see_also📖R-Loop Stress in Neurodegeneration80%

related🧪Selective Acid Sphingomyelinase Modulation Therapy80%

related🧪Circadian Rhythm Entrainment of Reactive Astrocytes80%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration80%

related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation80%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 80%

see_also📖Kidney-Brain Neurodegeneration Axis80%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer80%

related🧪Purinergic Signaling Polarization Control80%

related🧪Temporal Decoupling via Circadian Clock Reset80%

related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto80%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration80%

related🧪PARP1 Inhibition Therapy80%

see_also📖RNA-Targeted Therapies in Neurodegeneration80%

see_also📖Protein Aggregation Comparison in Neurodegeneration80%

see_also📖Tau Kinase Signaling Cascade in Alzheimer's Disease80%

see_also📖Synaptic Biomarkers in Neurodegeneration80%

related🧪Vocal Cord Neuroplasticity Stimulation80%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration80%

see_also📖Lipid Dysregulation in Neurodegeneration80%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener80%

related🧪Epigenetic Memory Erasure via TET2 Activation80%

related🧪Nutrient-Sensing Epigenetic Circuit Reactivation80%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N80%

related🧪Digital Twin-Guided Metabolic Reprogramming80%

see_also📖Neuronal Hyperexcitability in Neurodegeneration80%

see_also📖Molecular Chaperones in Neurodegeneration80%

related🧪Phase-Separated Organelle Targeting80%

related🧪Quantum Coherence Disruption in Cellular Communication80%

see_also📖Prion-Like Spread in Neurodegeneration80%

see_also📖mTOR Signaling Pathway in Neurodegeneration80%

related🧪Circadian Clock-Autophagy Synchronization80%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides80%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy80%

related🧪Retinal Vascular Microcirculation Rescue80%

see_also📖Sleep Disorders in Neurodegeneration80%

related🧪SASP-Mediated Cholinergic Synapse Disruption80%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration80%

related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme80%

see_also📖Retinal Degeneration Pathway in Neurodegeneration80%

see_also📖Pericyte Loss in Neurodegeneration80%

related🧪Mitochondrial SPM Synthesis Platform Engineering80%

see_also📖Endothelin Signaling Pathway in Neurodegeneration80%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration80%

see_also📖Therapeutic Targets in Neurodegeneration80%

see_also📖GDNF Signaling Pathway in Neurodegeneration80%

related🧪Lysosomal Calcium Channel Modulation Therapy80%

see_also📖Global Neurodegeneration Epidemiology80%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration80%

see_also📖interleukin-6-signaling-neurodegeneration80%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio80%

related🧪HDAC3-Selective Inhibition for Clock Reset80%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration80%

related🧪Glycine-Rich Domain Competitive Inhibition80%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration80%

see_also📖Glycosylation in Neurodegeneration80%

see_also📖RAN Translation in Neurodegeneration80%

see_also📖European Neurodegeneration Epidemiology80%

related🧪RAB27A-dependent extracellular vesicle engineering for mitoc80%

related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m80%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration80%

see_also📖Antibody Therapy in Neurodegeneration80%

see_also📖Sex Differences in Neurodegeneration80%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a80%

related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics80%

see_also📖Nitric Oxide Signaling in Neurodegeneration80%

see_also📖Hippocampal Neurogenesis in Neurodegeneration80%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration80%

related🧪Netrin-1 Gradient Restoration80%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones80%

see_also📖Endocannabinoid System in Neurodegeneration80%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration80%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration80%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)80%

see_also📖Paraptosis in Neurodegeneration80%

related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy80%

related🧪Selective HDAC3 Inhibition with Cognitive Enhancement80%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain80%

see_also📖Prion Diseases in Neurodegeneration80%

see_also📖COVID-19 Neurodegeneration Mechanism80%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat80%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison80%

see_also📖FA2H-Associated Neurodegeneration Pathway80%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration80%

related🧪Cryptic Exon Silencing Restoration80%

see_also📖IL-1 Signaling Pathway in Neurodegeneration80%

see_also📖Progesterone Signaling Pathway in Neurodegeneration80%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration80%

related🧪Complement C1q Subtype Switching80%

see_also📖Senescent Cell Clearance in Neurodegeneration80%

see_also📖Diffusion MRI (DTI) in Neurodegeneration80%

related🧪Mitochondrial RNA Granule Rescue Pathway80%

related🧪Nucleolar Stress Response Normalization80%

related🧪Complement C1q Mimetic Decoy Therapy80%

related🧪Circadian-Synchronized Proteostasis Enhancement80%

see_also📖Prion Protein Metabolism in Neurodegeneration80%

related🧪Orexin-Microglia Modulation Therapy80%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration80%

related🧪Transcriptional Autophagy-Lysosome Coupling80%

related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu80%

see_also📖Protein Aggregation Seeds in Neurodegeneration80%

related🧪Sphingomyelin Synthase Activators for Raft Remodeling80%

related🧪CX43 hemichannel engineering enables size-selective mitochon80%

see_also📖China Neurodegeneration Epidemiology80%

see_also📖T-Cell Dysfunction in Neurodegeneration80%

related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition80%

related🧪Senescence-Induced Lipid Peroxidation Spreading80%

see_also📖Integrated Stress Response in Neurodegeneration80%

see_also📖Neuropil Threads in Neurodegeneration80%

see_also📖Neurotensin Signaling in Neurodegeneration80%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati80%

see_also📖Neuroimaging Biomarkers for Neurodegeneration80%

related🧪Chaperone-Mediated APOE4 Refolding Enhancement80%

related🧪R-Loop Resolution Enhancement Therapy80%

related🧪Blood-Brain Barrier SPM Shuttle System80%

related🧪Autophagosome Maturation Checkpoint Control80%

related🧪Ocular Immune Privilege Extension80%

see_also📖DALY Methodology — Neurodegeneration80%

related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism80%

related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu80%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)80%

related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi80%

related🧪Purinergic P2Y12 Inverse Agonist Therapy80%

related🧪RNA Granule Nucleation Site Modulation80%

see_also📖PPAR Signaling Pathway in Neurodegeneration80%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen80%

related🧪Adenosine-Astrocyte Metabolic Reset80%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering80%

related🧪Lysosomal Positioning Dynamics Modulation80%

see_also📖Metal Homeostasis in Neurodegeneration80%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration80%

see_also📖Microglial Priming Pathway in Neurodegeneration80%

related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration80%

related🧪TFAM overexpression creates mitochondrial donor-recipient gr80%

see_also📖Galectin-3 Mechanism in Neurodegeneration80%

related🧪Lysosomal Membrane Repair Enhancement80%

related🧪Serine/Arginine-Rich Protein Kinase Modulation80%

related🧪Temporal TET2-Mediated Hydroxymethylation Cycling80%

related🧪Smartphone-Detected Motor Variability Correction80%

see_also📖Liquid Biopsy in Neurodegeneration80%

related🧪Multi-Modal Stress Response Harmonization80%

related🧪Mitochondrial-Lysosomal Contact Site Engineering80%

related🧪Glial Glycocalyx Remodeling Therapy80%

related🧪Flotillin-1 Stabilization Compounds80%

see_also📖Economic Burden — Neurodegeneration80%

related🧪Metabolic Switch Targeting for A1→A2 Repolarization80%

related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In80%

see_also📖Exosomal miR-155 in Neurodegeneration80%

related🧪DNMT1-Targeting Antisense Oligonucleotide Reset80%

related🧪Piezoelectric Nanochannel BBB Disruption80%

related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis80%

related🧪Hypocretin-Neurogenesis Coupling Therapy80%

see_also📖Amylin Signaling in Neurodegeneration80%

related🧪Microglial Purinergic Reprogramming80%

see_also📖RNA Splicing in Neurodegeneration80%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration80%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration80%

see_also📖Axon Guidance Pathways in Neurodegeneration80%

see_also📖Mitochondrial Fusion in Neurodegeneration80%

related🧪Lysosomal Enzyme Trafficking Correction80%

related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue80%

related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem80%

see_also📖SUMOylation in Neurodegeneration80%

related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming80%

related🧪Extracellular Matrix Stiffness Modulation80%

see_also📖Gangliosides in Neurodegeneration80%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio80%

related🧪SASP-Mediated Complement Cascade Amplification80%

related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation80%

related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri80%

related🧪Lipid Droplet Dynamics as Phenotype Switches80%

related🧪Axonal RNA Transport Reconstitution80%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr80%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration80%

related🧪Enteric Nervous System Prion-Like Propagation Blockade80%

related🧪Synthetic Biology Rewiring via Orthogonal Receptors80%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread80%

related🧪Mechanosensitive Ion Channel Reprogramming80%

related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor80%

see_also📖Manganese-Related Neurodegeneration (Manganism)80%

see_also📖Prognostic Biomarkers in Neurodegeneration80%

related🧪Chromatin Accessibility Restoration via BRD4 Modulation80%

related🧪Stress Granule Phase Separation Modulators80%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration80%

related🧪Near-infrared light therapy stimulates COX4-dependent mitoch80%

related🧪SASP-Driven Aquaporin-4 Dysregulation80%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration80%

see_also📖Copper Homeostasis in Neurodegeneration80%

related🧪Ephrin-B2/EphB4 Axis Manipulation80%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration80%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration80%

related🧪Glymphatic System-Enhanced Antibody Clearance Reversal80%

related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho80%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction80%

related🧪CYP46A1 Overexpression Gene Therapy80%

see_also📖Neuroimaging for Parkinsonian Syndromes (NCT03872102)80%

see_also📖MicroRNA Dysfunction in Neurodegeneration80%

related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai80%

see_also📖Computational Disease Models for Neurodegeneration80%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration80%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration80%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su80%

see_also📖Advanced Glycation End Products in Neurodegeneration80%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration80%

see_also📖acetylcholine-signaling-neurodegeneration80%

see_also📖NRF2 Signaling Pathway in Neurodegeneration80%

related🧪Circadian-Gated Maresin Biosynthesis Amplification80%

related🧪Competitive APOE4 Domain Stabilization Peptides80%

related🧪Sleep Spindle-Synaptic Plasticity Enhancement80%

see_also📖CaMKII Signaling Pathway in Neurodegeneration80%

see_also📖HMGB1 Signaling in Neurodegeneration80%

related🧪Membrane Cholesterol Gradient Modulators80%

see_also📖India Neurodegeneration Epidemiology80%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration80%

related🧪Pharmacological Enhancement of APOE4 Glycosylation80%

related🧪Perforant Path Presynaptic Terminal Protection Strategy80%

related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th80%

see_also📖NF-kB Signaling Pathway in Neurodegeneration80%

see_also📖Ribosome Dysfunction in Neurodegeneration80%

see_also📖Neural Circuits in Neurodegeneration80%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and80%

see_also📖Serotonergic Dysfunction in Neurodegeneration80%

related🧪Arginine Methylation Enhancement Therapy80%

see_also📖Sleep Dysfunction in Neurodegeneration80%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration80%

related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors80%

see_also📖Histone Modification Pathways in Neurodegeneration80%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration80%

related🧪Senescence-Activated NAD+ Depletion Rescue80%

related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation80%

see_also📖synaptic-vesicle-cycling-neurodegeneration80%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)80%

related🧪Microbial Inflammasome Priming Prevention80%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration80%

see_also📖Potential Impact Measures — Neurodegeneration80%

see_also📖Japan Neurodegeneration Epidemiology80%

see_also📖Paranodal Dysfunction in Neurodegeneration80%

see_also📖Down Syndrome Neurodegeneration Pathway80%

related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol80%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration80%

related🧪Vagal Afferent Microbial Signal Modulation80%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration80%

see_also📖Parthanatos in Neurodegeneration80%

related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection80%

related🧪SIRT6-NAD+ Axis Enhancement Therapy80%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration80%

related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho80%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration80%

see_also📖Neural Circuit Disruption in Neurodegeneration80%

related🧪Heat Shock Protein 70 Disaggregase Amplification80%

see_also📖Disease Progression & Staging in Neurodegeneration80%

see_also📖epigenetics-neurodegeneration80%

see_also📖Purinergic Signaling in Neurodegeneration80%

related🧪Biorhythmic Interference via Controlled Sleep Oscillations80%

related🧪GAP43-mediated tunneling nanotube stabilization enhances neu80%

see_also📖Orexin Signaling in Neurodegeneration80%

see_also📖Short Chain Fatty Acids in Neurodegeneration80%

see_also📖Exosomal Biomarkers in Neurodegeneration80%

related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 80%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration80%

see_also📖UPenn Observational Research Repository (NCT04715399)75%

see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE75%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

see_also📖APOE4 (Apolipoprotein E4)70%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739265%

see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime65%

see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St65%

see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 65%

see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial65%

see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M60%

see_also📖SNCA Gene Variants and Mutations60%

see_also📖CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD60%

see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas60%

see_also📖SNCA — Alpha-Synuclein Gene Entity Page60%

see_also📖PI-2620 Tau PET Phase 3 (NCT05456503) - FTLD and Atypical AD60%

see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc60%

see_also📖remternetug-anti-amyloid-alzheimers60%

see_also📖APOE2 (Apolipoprotein E2)60%

see_also📖MK-1167 Phase 2 AD Trial (MK-1167-008)60%

see_also📖PSP Liquid-Liquid Phase Separation and Biomolecular Condensa60%

see_also📖nct0550878960%

see_also📖APOE3 (Apolipoprotein E3)60%

related🧫Proposed experiment from debate on Epigenetic clocks and bio60%

related🧫s:** - Biochemical binding assays measuring PROTAC selectivi60%

related🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment60%

related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal60%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l60%

related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design60%

related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in60%

related🧫s:** - Temporal analysis showing mitochondrial defects prece60%

related🧫Prion Strain Diversity and Selective Vulnerability in CJD60%

related🧫Proposed experiment from debate on Senolytics targeting p16/60%

related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an60%

related🧫Experiment Index60%

related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 60%

related🧫Proposed experiment from debate on Epigenetic clocks and bio60%

related🧫DLB Cognitive Fluctuation Mechanism Experiment60%

related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo60%

related🧫NPH Glymphatic System Interaction Experiment60%

related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal60%

related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin60%

related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel60%

related🧫Proposed experiment from debate on Perivascular spaces and g60%

related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka60%

related🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 60%

see_also📖Neurodegeneration60%

related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G60%

related🧫Epigenetic Dysregulation in Huntington's Disease — Ther60%

related🧫s:** - Test MCU overexpression specifically in layer II neur60%

related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre60%

related🧫Protein Aggregation Kinetic Validation Results60%

related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M60%

related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec60%

related🧫Tau Pathology Initiation Zone Identification60%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur60%

related🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr60%

related🧫Proposed experiment from debate on Microglia activate astroc60%

related🧫s:** - Test tau spreading in AQP4 knockout vs wild-type mice60%

related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy60%

related🧫Proposed experiment from debate on Mitochondrial transfer be60%

related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi60%

related🧫s:** - Compare uptake with/without magnetic particles using 60%

related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 60%

related🧫Genetic Risk Modifiers in DLB Phenotype60%

related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional60%

related🧫s:** - Dose-response studies showing therapeutic window with60%

related🧫Experiment Scoring Methodology60%

related🧫Proposed experiment from debate on Perivascular spaces and g60%

related🧫Tau Co-Pathology in DLB Clinical Heterogeneity60%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l60%

related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras60%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur60%

related🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro60%

related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati60%

related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P60%

related🧫Proposed experiment from debate on Mitochondrial transfer be60%

see_also📖Multimodal Diagnostic Algorithm for CBS and PSP55%

see_also📖Long-term Effects of Hearing Intervention on Brain Health in55%

related🧫Proposed experiment from debate on Epigenetic clocks and bio54%

related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G54%

related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design54%

related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati54%

related🧫Proposed experiment from debate on Epigenetic clocks and bio54%

related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin54%

related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras54%

related🧫Tau Co-Pathology in DLB Clinical Heterogeneity54%

related🧫s:** - Compare uptake with/without magnetic particles using 54%

related🧫Genetic Risk Modifiers in DLB Phenotype54%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur54%

related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo54%

related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel54%

related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an54%

related🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro54%

related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P54%

related🧫Proposed experiment from debate on Perivascular spaces and g54%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l54%

related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal54%

related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 54%

related🧫s:** - Test tau spreading in AQP4 knockout vs wild-type mice54%

related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka54%

related🧫Experiment Index54%

related🧫s:** - Test MCU overexpression specifically in layer II neur54%

related🧫s:** - Biochemical binding assays measuring PROTAC selectivi54%

related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec54%

related🧫s:** - Temporal analysis showing mitochondrial defects prece54%

related🧫NPH Glymphatic System Interaction Experiment54%

related🧫DLB Cognitive Fluctuation Mechanism Experiment54%

related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal54%

related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 54%

related🧫Tau Pathology Initiation Zone Identification54%

related🧫Experiment Scoring Methodology54%

related🧫Protein Aggregation Kinetic Validation Results54%

related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M54%

related🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment54%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l54%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur54%

related🧫Proposed experiment from debate on Senolytics targeting p16/54%

related🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 54%

related🧫Proposed experiment from debate on Perivascular spaces and g54%

related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional54%

related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi54%

related🧫Proposed experiment from debate on Mitochondrial transfer be54%

related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy54%

related🧫Prion Strain Diversity and Selective Vulnerability in CJD54%

related🧫Epigenetic Dysregulation in Huntington's Disease — Ther54%

related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre54%

related🧫Proposed experiment from debate on Microglia activate astroc54%

related🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr54%

related🧫s:** - Dose-response studies showing therapeutic window with54%

related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in54%

related🧫Proposed experiment from debate on Mitochondrial transfer be54%

mentions🧪Lysosomal Enzyme Trafficking Correction50%

mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%

related🔬Senescent cell clearance as neurodegeneration therapy50%

mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%

mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis50%

mentions🧪APOE-Dependent Autophagy Restoration50%

related🔬What are the mechanisms underlying selective vulnerability o50%

mentions🧪Noradrenergic-Tau Propagation Blockade50%

mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%

mentions🧪HDAC3-Selective Inhibition for Clock Reset50%

mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

mentions🧪Mitochondrial RNA Granule Rescue Pathway50%

mentions🧪TREM2-mediated microglial tau clearance enhancement50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement50%

related🔬What are the mechanisms underlying sleep disruption as cause50%

mentions🧪Pharmacological Enhancement of APOE4 Glycosylation50%

mentions🧪Gut Barrier Permeability-α-Synuclein Axis Modulation50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%

see_also📖CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subc50%

mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists50%

mentions🧪Arginine Methylation Enhancement Therapy50%

see_also📖PSP and Idiopathic Normal Pressure Hydrocephalus: Clinical O50%

mentions🔬Epigenetic reprogramming in aging neurons50%

mentions🧪Vocal Cord Neuroplasticity Stimulation50%

see_also📖Rigidity in Corticobasal Syndrome50%

see_also📖Digital Therapeutic Platform for Swallowing and Drooling Pro50%

mentions🧪Complement C1q Subtype Switching50%

mentions🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

mentions🧪Piezoelectric Nanochannel BBB Disruption50%

mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

mentions🧪Microbial Inflammasome Priming Prevention50%

related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

related🔬Epigenetic reprogramming in aging neurons50%

mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

mentions🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat50%

see_also📖Neuroinflammation in Parkinson's Disease Dementia and D50%

related🔬What are the mechanisms underlying selective vulnerability o50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

see_also📖al002-trem2-agonist-alzheimers50%

mentions🧪Phase-Separated Organelle Targeting50%

see_also📖Braak Staging and Tau Propagation Pathway50%

related🔬What are the mechanisms underlying synaptic pruning by micro50%

mentions🧪Ganglioside Rebalancing Therapy50%

mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%

mentions🧪Mechanosensitive Ion Channel Reprogramming50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%

mentions🔬What are the mechanisms underlying selective vulnerability o50%

see_also📖CBS/PSP Panxoneopathy and Membrane Biology50%

mentions🧪Microglial Purinergic Reprogramming50%

see_also📖PCDH19-Related Epilepsy (EFMR) — Preclinical Gene Therapy Pr50%

mentions🧪SASP-Mediated Complement Cascade Amplification50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

mentions🧪Lipid Droplet Dynamics as Phenotype Switches50%

mentions🧪Sleep Spindle-Synaptic Plasticity Enhancement50%

mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%

mentions🔬What are the mechanisms underlying perivascular spaces and g50%

mentions🧪Vagal Afferent Microbial Signal Modulation50%

mentions🧪Axonal RNA Transport Reconstitution50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Nucleolar Stress Response Normalization50%

mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%

mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%

mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics50%

mentions🔬Extracellular vesicle biomarkers for early AD detection50%

mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%

mentions🔬Senescent cell clearance as neurodegeneration therapy50%

mentions🧪Netrin-1 Gradient Restoration50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

mentions🔬Investigate prion-like spreading of tau pathology through co50%

see_also📖Geniposide for Alzheimer's disease - immune biomarker t50%

mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho50%

see_also📖APOE4 and Alzheimer's Disease Risk50%

mentions🔬What are the mechanisms underlying synaptic pruning by micro50%

see_also📖Pesticides and Parkinson Disease (Pest-PD) — NCT0642031050%

mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%

mentions🧪Circadian-Synchronized LRP1 Pathway Activation50%

mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%

see_also📖Metabolic Dysfunction and Insulin Resistance in Progressive 50%

related🔬What are the mechanisms underlying protein aggregation cross50%

mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

see_also📖ALS Therapeutic Landscape — Programs by Phase and Modality50%

mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%

see_also📖Systemic Infection and Tau Pathology Acceleration50%

mentions🧪Quantum Coherence Disruption in Cellular Communication50%

mentions🧪Circadian Clock-Autophagy Synchronization50%

mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%

mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%

mentions🧪CX43 hemichannel engineering enables size-selective mitochon50%

mentions🧪Lysosomal Positioning Dynamics Modulation50%

mentions🧪Circadian-Gated Maresin Biosynthesis Amplification50%

mentions🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution50%

mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%

mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp50%

mentions🧪Mitochondrial SPM Synthesis Platform Engineering50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

see_also📖A Multicenter, Phase III, Randomized, Double Blind, Placebo-50%

mentions🧪Temporal Decoupling via Circadian Clock Reset50%

see_also📖Healthcare Economics and Cost of Illness in Progressive Supr50%

mentions🧪Stress Granule Phase Separation Modulators50%

see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh50%

see_also📖GBA Glucocerebrosidase Dysfunction and Parkinson's Dise50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%

mentions🧪Mitochondrial-Lysosomal Contact Site Engineering50%

mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu50%

related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%

mentions🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection50%

mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%

mentions🧪Flotillin-1 Stabilization Compounds50%

mentions🧪PARP1 Inhibition Therapy50%

mentions🧪Purinergic Signaling Polarization Control50%

mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%

mentions🧪Blood-Brain Barrier SPM Shuttle System50%

mentions🧪Glycine-Rich Domain Competitive Inhibition50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

see_also📖Synaptic Loss and Dysfunction Pathway50%

mentions🔬What are the mechanisms underlying blood-brain barrier trans50%

mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%

mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%

mentions🧪Lysosomal Calcium Channel Modulation Therapy50%

mentions🧪Cross-Seeding Prevention Strategy50%

related🔬Epigenetic reprogramming in aging neurons50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

see_also📖A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month50%

related🔬Investigate prion-like spreading of tau pathology through co50%

mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%

mentions🧪Autophagosome Maturation Checkpoint Control50%

mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%

mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%

mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

mentions🧪Ephrin-B2/EphB4 Axis Manipulation50%

mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho50%

see_also📖Glymphatic Clearance Hypothesis — Impaired Aβ and Tau Remova50%

mentions🧪Membrane Cholesterol Gradient Modulators50%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides50%

see_also📖Tau Seeding and Propagation Pathway50%

mentions🧪SASP-Mediated Cholinergic Synapse Disruption50%

mentions🧪Retinal Vascular Microcirculation Rescue50%

mentions🧪Sphingomyelin Synthase Activators for Raft Remodeling50%

see_also📖A 6-month & 18-month Prospective, Randomized, Placebo-co50%

mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%

mentions🧪Multi-Modal Stress Response Harmonization50%

mentions🧪R-Loop Resolution Enhancement Therapy50%

mentions🧪Lysosomal Membrane Repair Enhancement50%

mentions🧪Reelin-Mediated Cytoskeletal Stabilization Protocol50%

mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%

mentions🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%

mentions🧪APOE-TREM2 Interaction Modulation50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%

mentions🧪Extracellular Matrix Stiffness Modulation50%

mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%

mentions🧪Low Complexity Domain Cross-Linking Inhibition50%

mentions🧪Orexin-Microglia Modulation Therapy50%

see_also📖Shared Mechanisms Between Alzheimer and Parkinson Disease50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors50%

see_also📖Mirror Therapy and Sensory Re-education in Corticobasal Synd50%

mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

see_also📖Speech Therapy and Communication Aids in Corticobasal Syndro50%

mentions🧪Mitochondrial Transfer Pathway Enhancement50%

mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa50%

mentions🧪Glial Glycocalyx Remodeling Therapy50%

mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

see_also📖Phase 3 Study to Compare the Efficacy and Safety of Masitini50%

mentions🔬What are the mechanisms underlying apoe4 structural biology 50%

mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

see_also📖Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pi50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

see_also📖Hereditary Sensory and Autonomic Neuropathy (HSAN)50%

mentions🧪Senescence-Induced Lipid Peroxidation Spreading50%

see_also📖p-Tau Biomarker in Immunoglobulin Light Chain and Transthyre50%

see_also📖Glial Tau Pathology in PSP and CBD50%

related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%

mentions🔬What are the mechanisms underlying tdp-43 phase separation t50%

mentions🧪Enteric Nervous System Prion-Like Propagation Blockade50%

mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

mentions🧪Transcriptional Autophagy-Lysosome Coupling50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation50%

mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr50%

mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%

mentions🧪Digital Twin-Guided Metabolic Reprogramming50%

mentions🧪Senescence-Activated NAD+ Depletion Rescue50%

mentions🧪Circadian-Synchronized Proteostasis Enhancement50%

see_also📖Physical and Occupational Therapy in Corticobasal Syndrome50%

related🔬What are the mechanisms underlying synaptic pruning by micro50%

mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%

mentions🧪RNA Granule Nucleation Site Modulation50%

mentions🧪Complement C1q Mimetic Decoy Therapy50%

mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors50%

mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%

related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto50%

mentions🧪Adenosine-Astrocyte Metabolic Reset50%

mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%

mentions🧪Senescent Cell Mitochondrial DNA Release50%

see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 50%

mentions🧪Aquaporin-4 Polarization Rescue50%

related🔬RNA binding protein dysregulation across ALS FTD and AD50%

mentions🧪Ocular Immune Privilege Extension50%

mentions🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme50%

mentions🧪Senescence-Associated Myelin Lipid Remodeling50%

see_also📖Blood-Brain Barrier Dysfunction and Therapeutic Delivery for50%

mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%

see_also📖Utilisation of Health Services and Quality of Life in Atypic50%

mentions🧪CYP46A1 Overexpression Gene Therapy50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

mentions🧪Epigenetic Memory Erasure via TET2 Activation50%

related🔬What are the mechanisms underlying sleep disruption as cause50%

mentions🧪TREM2-Dependent Microglial Senescence Transition50%

see_also📖MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acid50%

mentions🧪Smartphone-Detected Motor Variability Correction50%

mentions🧪Cryptic Exon Silencing Restoration50%

see_also📖Blood-Brain Barrier and Neuroimmune Interface in CBS/PSP50%

mentions🔬What are the mechanisms underlying what are the mechanisms b50%

mentions🧪Sphingolipid Metabolism Reprogramming50%

mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%

mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%

related🔬Extracellular vesicle biomarkers for early AD detection50%

mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%

see_also📖Glymphatic and Vascular Clearance Dysfunction in 4R-Tauopath50%

see_also📖Postural Dysfunction and Abnormalities in Corticobasal Syndr45%

see_also📖alexander-disease45%

see_also📖Sleep Architecture Changes in CBS and PSP45%

see_also📖LRRK2 Gene Variants and Mutations45%

see_also📖ABCA7 Lipid Transport and Microglial Phagocytosis AD Causal 45%

see_also📖Alpha-Synuclein Seeding Assays (RT-QuIC and PMCA)45%

see_also📖A Phase III, Randomized, Double-Blind, Placebo-Controlled, M45%

see_also📖Neuroresilience Mechanisms and Evidence45%

see_also📖Multi-Analyte Biomarker Panel for Parkinson's Disease D45%

see_also📖Safety and Clinical Outcomes Study: Amniotic and Umbilical C45%

see_also📖GBA Brain Molecular Imaging and Blood Biomarkers for Precisi45%

see_also📖Japanese and German Case Series in Corticobasal Degeneration45%

see_also📖Investment Landscape: ALS45%

see_also📖Hemiballismus and Hemichorea in Corticobasal Syndrome45%

see_also📖Callosal Disconnection and Interhemispheric Dysfunction in C45%

see_also📖Alpha-Synuclein PET Imaging and Biomarker Advances45%

see_also📖Pupillary and Visual Dysfunction in Progressive Supranuclear45%

see_also📖Somatic Mutations and Brain Mosaicism45%

see_also📖Aquaporin-4 (AQP4) - Glymphatic System Biomarker45%

see_also📖Whole-Body Photobiomodulation for Motor and Cognitive Change45%

see_also📖BLAAC PD - Black and African Americans Connections to PD (NC45%

see_also📖Caregiver Support and Palliative Care in Atypical [Parkinson45%

see_also📖Vocational Rehabilitation and Driving in Corticobasal Syndro45%

see_also📖TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain45%

see_also📖FTDP-17 Clinical Phenotypes and Disease Progression45%

see_also📖FTLD-TDP Subtypes and Mechanisms45%

see_also📖Pseudobulbar Affect and Emotional Lability in Corticobasal S45%

see_also📖Gait and Upper Limb Evaluation in PSP (NCT07136844)45%

see_also📖LRRK2 Kinase Activation and Endolysosomal Dysfunction in Par45%

see_also📖Advanced Proteolysis and Ubiquitin System Targeting in CBS/P45%

see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di45%

see_also📖Social Behaviors and Quality of Life in Parkinson's Dis45%

see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI45%

see_also📖Investment Landscape: Huntington's Disease45%

see_also📖HIV-Associated Neurocognitive Disorders (HAND)45%

see_also📖Sandhoff Disease45%

see_also📖Gait and Balance Disorders in Progressive Supranuclear Palsy45%

see_also📖SNCA A53T45%

see_also📖HLA Haplotypes and Neuroinflammatory Profiles in PSP45%

see_also📖ALS Biomarkers and Disease Monitoring45%

see_also📖Sialorrhea and Drooling in Corticobasal Syndrome45%

see_also📖Gait Analysis Parameter and Upper Limb Evaluation in Neurolo45%

see_also📖MSA Clinical Features and Diagnosis45%

see_also📖Cognitive and Speech Rehabilitation in CBS (NCT05823421)45%

see_also📖Trontinemab (RO7126209) Phase 3 Trial — TRONTIER 2 (NCT0717045%

see_also📖Jervell and Lange-Nielsen Syndrome45%

see_also📖Speech and Voice Disorders in PSP45%

see_also📖PSP Lysosomal Dysfunction and Autophagy Impairment45%

see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime45%

see_also📖Investment Landscape: Parkinson's Disease45%

see_also📖Clostridium Butyricum for Motor and Non-motor Symptoms in Pa45%

see_also📖First-in-Human 4R Tau Ligand Study in PSP (NCT07348276)45%

see_also📖VEGF and Angiogenesis Dysregulation in CBS/PSP45%

see_also📖TARDBP Mutations in Amyotrophic Lateral Sclerosis45%

see_also📖Dysphagia and Nutritional Management in Corticobasal Syndrom45%

see_also📖Alexander Disease Genetic Variants45%

see_also📖Myoclonus and Cortical Hyperexcitability in Corticobasal Syn45%

see_also📖UB-311 Alzheimer's Vaccination Trial45%

see_also📖C9orf72 Repeat Expansions in CBS and PSP45%

see_also📖PSP Tau Propagation and Spreading Mechanisms45%

see_also📖Caregiver Burden and Support in Corticobasal Syndrome45%

see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease45%

see_also📖Environmental Toxins and Parkinson's Risk45%

see_also📖PSP Weight Loss and Cachexia45%

see_also📖mTOR Signaling in Autophagy and Lysosomal Function45%

see_also📖Pupillometry and Chromatic Pupillometry in Corticobasal Synd45%

see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease45%

see_also📖CNversyt and Megan Rodden ALS Trials45%

see_also📖Simultanagnosia and Balint's Syndrome in Corticobasal S45%

see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease45%

see_also📖Speech and Language Deficits in Corticobasal Syndrome45%

see_also📖DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulat45%

see_also📖Clinical Phenotypes and Subtypes of Corticobasal Syndrome45%

see_also📖AAIC 2026: Tau-PET Imaging and Fluid Biomarker Integration45%

see_also📖Iron and Neuromelanin Accumulation in PSP45%

see_also📖Donanemab TRAILBLAZER-ALZ 2 Trial45%

see_also📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy45%

see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers45%

see_also📖Silymarin for Neuroprotection and Symptom Management in Park45%

see_also📖Natural History and Prognosis of Corticobasal Syndrome45%

see_also📖Quality of Life and Caregiver Burden in PSP (NCT03638505)45%

see_also📖Polygenic Risk Score Integration Panel for Alzheimer's 45%

see_also📖Imaging Biomarkers for Corticobasal Syndrome and Progressive45%

see_also📖ATP13A9 and Parkinson's Disease45%

see_also📖Voice and Speech in Corticobasal Syndrome45%

see_also📖NLRP3 Inflammasome Inhibitors for Parkinson's Disease45%

see_also📖Nutritional Support and Dietary Interventions in Corticobasa45%

see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451645%

see_also📖A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-C45%

see_also📖NLRP3 Inhibitors in Parkinson's Disease: Research and C45%

see_also📖Clinical Efficacy and Mechanism of tDCS for Dysphagia in Par45%

see_also📖Investment Landscape: Frontotemporal Dementia45%

see_also📖A Phase 3, Randomized, Double-blind, Placebo-controlled, Par45%

see_also📖Quality of Life and Caregiver Burden in Progressive Supranuc45%

related🧪Vagal Afferent Microbial Signal Modulation40%

related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination40%

related🧪Circadian Rhythm Entrainment of Reactive Astrocytes40%

related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration40%

related🧪Competitive APOE4 Domain Stabilization Peptides40%

related🧪Cryptic Exon Silencing Restoration40%

related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection40%

related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto40%

related🧪Selective HDAC3 Inhibition with Cognitive Enhancement40%

related🧪Epigenetic Memory Erasure via TET2 Activation40%

related🧪Orexin-Microglia Modulation Therapy40%

related🧪RNA Granule Nucleation Site Modulation40%

related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati40%

related🧪Digital Twin-Guided Metabolic Reprogramming40%

related🧪Lysosomal Enzyme Trafficking Correction40%

related🧪Purinergic Signaling Polarization Control40%

related🧪Multi-Modal Stress Response Harmonization40%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides40%

related🧪CYP46A1 Overexpression Gene Therapy40%

related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho40%

related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi40%

related🧪Synthetic Biology Rewiring via Orthogonal Receptors40%

related🧪Chaperone-Mediated APOE4 Refolding Enhancement40%

related🧪Stress Granule Phase Separation Modulators40%

related🧪Temporal Decoupling via Circadian Clock Reset40%

related🧪Ocular Immune Privilege Extension40%

related🧪Noradrenergic-Tau Propagation Blockade40%

related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu40%

related🧪SASP-Driven Aquaporin-4 Dysregulation40%

related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis40%

related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation40%

related🧪Near-infrared light therapy stimulates COX4-dependent mitoch40%

related🧪Mechanosensitive Ion Channel Reprogramming40%

related🧪Complement C1q Subtype Switching40%

related🧪Smartphone-Detected Motor Variability Correction40%

related🧪DNMT1-Targeting Antisense Oligonucleotide Reset40%

related🧪TFAM overexpression creates mitochondrial donor-recipient gr40%

related🧪Biorhythmic Interference via Controlled Sleep Oscillations40%

related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue40%

related🧪KDM6A-Mediated H3K27me3 Rejuvenation40%

related🧪Phase-Separated Organelle Targeting40%

related🧪Arginine Methylation Enhancement Therapy40%

related🧪PARP1 Inhibition Therapy40%

related🧪Enteric Nervous System Prion-Like Propagation Blockade40%

related🧪Membrane Cholesterol Gradient Modulators40%

related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation40%

related🧪Sphingolipid Metabolism Reprogramming40%

related🧪CX43 hemichannel engineering enables size-selective mitochon40%

related🧪Transcriptional Autophagy-Lysosome Coupling40%

related🧪Aquaporin-4 Polarization Rescue40%

related🧪Mitochondrial-Lysosomal Contact Site Engineering40%

related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors40%

related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy40%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer40%

related🧪Selective Acid Sphingomyelinase Modulation Therapy40%

related🧪Flotillin-1 Stabilization Compounds40%

related🧪Lipid Droplet Dynamics as Phenotype Switches40%

related🧪Lysosomal Calcium Channel Modulation Therapy40%

related🧪Sleep Spindle-Synaptic Plasticity Enhancement40%

related🧪Serine/Arginine-Rich Protein Kinase Modulation40%

related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%

related🧪Heat Shock Protein 70 Disaggregase Amplification40%

related🧪Lysosomal Positioning Dynamics Modulation40%

related🧪Senescence-Induced Lipid Peroxidation Spreading40%

related🧪Senescence-Activated NAD+ Depletion Rescue40%

related🧪Glial Glycocalyx Remodeling Therapy40%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%

related🧪Microglial Purinergic Reprogramming40%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones40%

related🧪Sphingomyelin Synthase Activators for Raft Remodeling40%

related🧪Circadian-Gated Maresin Biosynthesis Amplification40%

related🧪Piezoelectric Nanochannel BBB Disruption40%

related🧪Mitochondrial Transfer Pathway Enhancement40%

related🧪Ganglioside Rebalancing Therapy40%

related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution40%

related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat40%

related🧪Pharmacological Enhancement of APOE4 Glycosylation40%

mentions🔬RNA binding protein dysregulation across ALS FTD and AD40%

related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)40%

related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists40%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy40%

related🧪Complement C1q Mimetic Decoy Therapy40%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%

related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%

related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation40%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction40%

related🧪Hypocretin-Neurogenesis Coupling Therapy40%

related🧪SIRT6-NAD+ Axis Enhancement Therapy40%

related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming40%

related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%

related🧪Netrin-1 Gradient Restoration40%

related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%

related🧪Circadian-Synchronized Proteostasis Enhancement40%

related🧪Senescence-Associated Myelin Lipid Remodeling40%

related🧪Vocal Cord Neuroplasticity Stimulation40%

related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu40%

related🧪TET2-Mediated Demethylation Rejuvenation Therapy40%

related🧪Circadian Clock-Autophagy Synchronization40%

mentions🔬What are the mechanisms underlying rna binding protein dysre40%

related🧪Lysosomal Membrane Repair Enhancement40%

related🧪SASP-Mediated Cholinergic Synapse Disruption40%

related🧪Blood-Brain Barrier SPM Shuttle System40%

related🧪Senescent Cell Mitochondrial DNA Release40%

related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 40%

related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri40%

related🧪Metabolic Switch Targeting for A1→A2 Repolarization40%

related🧪Extracellular Matrix Stiffness Modulation40%

related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol40%

related🧪SASP-Mediated Complement Cascade Amplification40%

related🧪Mitochondrial SPM Synthesis Platform Engineering40%

related🧪Glycine-Rich Domain Competitive Inhibition40%

related🧪R-Loop Resolution Enhancement Therapy40%

related🧪Mitochondrial RNA Granule Rescue Pathway40%

related🧪Retinal Vascular Microcirculation Rescue40%

related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor40%

related🧪Nucleolar Stress Response Normalization40%

related🧪Quantum Coherence Disruption in Cellular Communication40%

related🧪RAB27A-dependent extracellular vesicle engineering for mitoc40%

related🧪GAP43-mediated tunneling nanotube stabilization enhances neu40%

related🧪Cross-Seeding Prevention Strategy40%

related🧪HDAC3-Selective Inhibition for Clock Reset40%

related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%

related🧪Ephrin-B2/EphB4 Axis Manipulation40%

related🧪Low Complexity Domain Cross-Linking Inhibition40%

related🧪Axonal RNA Transport Reconstitution40%

related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme40%

related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In40%

related🧪Temporal TET2-Mediated Hydroxymethylation Cycling40%

related🧪Purinergic P2Y12 Inverse Agonist Therapy40%

related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai40%

related🧪Glymphatic System-Enhanced Antibody Clearance Reversal40%

related🧪Adenosine-Astrocyte Metabolic Reset40%

related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism40%

related🧪Circadian-Synchronized LRP1 Pathway Activation40%

related🧪Autophagosome Maturation Checkpoint Control40%

related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho40%

related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%

related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics40%

related🧪Microbial Inflammasome Priming Prevention40%

mentions🔬What are the mechanisms underlying protein aggregation cross40%

related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition40%

related🧪Perforant Path Presynaptic Terminal Protection Strategy40%

Reference URLs

Canonical (singular)/artifact/wiki-proteins-snx3-proteincanonical

Canonical (plural, REST)/artifacts/wiki-proteins-snx3-proteinalias

API (JSON)/api/artifacts/wiki-proteins-snx3-proteinapi

Citation — BibTeX/artifacts/wiki-proteins-snx3-protein/cite?fmt=bibtexexport

Citation — RIS/artifacts/wiki-proteins-snx3-protein/cite?fmt=risexport

Citation — CSL-JSON/artifacts/wiki-proteins-snx3-protein/cite?fmt=cslexport

Embed this artifact

Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.

HTML iframe

<iframe src="http://scidex.ai/artifact/wiki-proteins-snx3-protein?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>

Markdown link

[SNX3 Protein — Sorting Nexin 3 in Neurodegeneration](http://scidex.ai/artifact/wiki-proteins-snx3-protein)

Direct URL

http://scidex.ai/artifact/wiki-proteins-snx3-protein

Preview

🔄 Adjacent Artifacts Recommended based on your interests

💬 Discussion

Loading comments...

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

SNX3 Protein — Sorting Nexin 3 in Neurodegeneration

SNX3 Protein — Sorting Nexin 3 in Neurodegeneration

Overview

SNX3 Protein — Sorting Nexin 3 in Neurodegeneration

Overview

Molecular Function

Domain Architecture

Retromer Recruitment

Cargo Recognition

Retromer Assembly

Role in Cellular Trafficking

Endosomal Sorting

Early Endosome Function

Cargo Selection

Protein Trafficking Pathways

Lysosomal Pathway

Recycling Pathway

Role in Alzheimer's Disease

APP Processing

Retromer Dysfunction

Tau Pathology Connection

Neuroinflammation

Role in Parkinson's Disease

Alpha-Synuclein Clearance

LRRK2 Interaction

Mitochondrial Quality Control

Dopaminergic Neuron Vulnerability

Autophagy and Protein Clearance

Autophagosome Formation

Selective Autophagy

Lysosomal Function

Synaptic Function

Synaptic Vesicle Trafficking

Postsynaptic Function

Axonal Transport

Therapeutic Implications

Targeting SNX3 for Neuroprotection

Small Molecule Approaches

Biomarker Potential

Protein-Protein Interactions

Core Retromer Components

Cargo Proteins

Lipid Interactions

Cellular Pathways

Endosomal Maturation

Early Endosomes

Sorting Endosomes

Late Endosomes

Protein Quality Control

Aggregate Clearance

Misfolded Protein Handling

Neuroimmune Function

Brain Cell Type-Specific Functions

Neurons

Astrocytes

Microglia

Oligodendrocytes

Comparison with Other Sorting Nexins

SNX Family Overview

SNX3-Specific Features

Genetic Studies

SNX3 Variants

Single Nucleotide Polymorphisms (SNPs)

Disease-Associated Variants

Expression Studies

Model Systems

Cell Culture Models

Animal Models

Findings from Models

Clinical Translation

Therapeutic Approaches

Gene Therapy

Small Molecules

Combination Therapy

Clinical Development

Current Status

Challenges

See Also

External Links